Literature DB >> 27956112

Risk factors for complications of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass.

Piotr Major1, Michał Wysocki2, Michał Pędziwiatr3, Magdalena Pisarska4, Jadwiga Dworak5, Piotr Małczak6, Andrzej Budzyński7.   

Abstract

BACKGROUND: Although bariatric procedures are considered safe, yet still they involve a risk of possible perioperative complications. Identification of risk factors for complications would allow for appropriate preoperative optimization of the patient, as well as reasonable postoperative care and early diagnosis and treatment of possible complications. The aim of this study was to determine the risk factors for perioperative complications after laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB).
MATERIAL AND METHODS: A retrospective analysis of prospectively collected data of patients operated for morbid obesity. Regarding postoperative complications defined as adverse events occurring within 30 days of the procedure. Factors associated with patient characteristics and those related to the surgical procedure were determined. 408 patients met inclusion criteria and were submitted to surgical treatment. LSG and LRYGB were performed in 233 and 175 patients, respectively.
RESULTS: Complications were observed in 30 (7.3%) patients. The maximum preoperative body weight and BMI, as well as body weight and BMI on the day of surgery were associated with increased complication rate. The type of the procedure did not influence perioperative complications (LRYGB vs. LSG; OR: 1.14; CI: 0.53-2.44; p = 0.74). Although operative time statistically significantly increased the risk of complications, it did not seem clinically relevant (OR: 1.01; CI: 1.00-1.02; p = 0.003). An increase in the number of stapler firings used significantly increased complication rate only in LSG group.
CONCLUSION: Longer duration of LSG and the increase in the number of stapler firings used during LSG should alert a surgeon to an increased risk of postoperative complications. In patients submitted to LRYGB the risk of possible complications increases with BMI.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gastric bypass; Postoperative complications; Risk factors; Sleeve gastrectomy

Mesh:

Year:  2016        PMID: 27956112     DOI: 10.1016/j.ijsu.2016.12.012

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  10 in total

1.  Management of Slipped Gastric Bands via Creation of a De Novo Tunnel and Band Replacement: a Single-Centre Experience.

Authors:  Roshani Vijaykumar Patel; Patrick Woodburn; James R A Skipworth; William James Buchanan Smellie
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

2.  Influence of Preoperative Weight Loss on Outcomes of Bariatric Surgery for Patients Under the Enhanced Recovery After Surgery Protocol.

Authors:  Tomasz Stefura; Jakub Droś; Artur Kacprzyk; Mateusz Wierdak; Monika Proczko-Stepaniak; Michał Szymański; Magdalena Pisarska; Piotr Małczak; Mateusz Rubinkiewicz; Michał Wysocki; Anna Rzepa; Michał Pędziwiatr; Andrzej Budzyński; Piotr Major
Journal:  Obes Surg       Date:  2019-04       Impact factor: 4.129

3.  Laparoscopic Sleeve Gastrectomy with Omentopexy: Is It Really a Promising Method?-A Systematic Review with Meta-analysis.

Authors:  Piotr Zarzycki; Jan Kulawik; Piotr Małczak; Mateusz Rubinkiewicz; Mateusz Wierdak; Piotr Major
Journal:  Obes Surg       Date:  2021-03-06       Impact factor: 4.129

4.  Analysis of Laparoscopic Sleeve Gastrectomy Learning Curve and Its Influence on Procedure Safety and Perioperative Complications.

Authors:  Piotr Major; Michał Wysocki; Jadwiga Dworak; Michał Pędziwiatr; Magdalena Pisarska; Mateusz Wierdak; Anna Zub-Pokrowiecka; Michał Natkaniec; Piotr Małczak; Michał Nowakowski; Andrzej Budzyński
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

5.  A Hub and Spoke Learning Program in Bariatric Surgery in a Small Region of Italy.

Authors:  Antonio Buondonno; Pasquale Avella; Micaela Cappuccio; Andrea Scacchi; Roberto Vaschetti; Giancarlo Di Marzo; Pietro Maida; Claudio Luciani; Bruno Amato; Maria Chiara Brunese; Daniela Esposito; Lucio Selvaggi; Germano Guerra; Aldo Rocca
Journal:  Front Surg       Date:  2022-03-24

6.  Postoperative Care and Functional Recovery After Laparoscopic Sleeve Gastrectomy vs. Laparoscopic Roux-en-Y Gastric Bypass Among Patients Under ERAS Protocol.

Authors:  Piotr Major; Tomasz Stefura; Piotr Małczak; Michał Wysocki; Jan Witowski; Jan Kulawik; Mateusz Wierdak; Magdalena Pisarska; Michał Pędziwiatr; Andrzej Budzyński
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

7.  Integrative genomics reveal a role for MCPIP1 in adipogenesis and adipocyte metabolism.

Authors:  Magdalena Losko; Dobrochna Dolicka; Natalia Pydyn; Urszula Jankowska; Sylwia Kedracka-Krok; Maria Kulecka; Agnieszka Paziewska; Michal Mikula; Piotr Major; Marek Winiarski; Andrzej Budzynski; Jolanta Jura
Journal:  Cell Mol Life Sci       Date:  2019-12-31       Impact factor: 9.261

Review 8.  Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know!

Authors:  Ioannis A Ziogas; Konstantinos Zapsalis; Dimitrios Giannis; Georgios Tsoulfas
Journal:  World J Hepatol       Date:  2020-10-27

9.  Type 2 Diabetes Remission 5 Years After Laparoscopic Sleeve Gastrectomy: Multicenter Cohort Study.

Authors:  Magdalena Mizera; Michał Wysocki; Katarzyna Bartosiak; Paula Franczak; Hady Razak Hady; Piotr Kalinowski; Piotr Myśliwiec; Michał Orłowski; Rafał Paluszkiewicz; Jerzy Piecuch; Jacek Szeliga; Maciej Walędziak; Piotr Major; Michał Pędziwiatr
Journal:  Obes Surg       Date:  2020-11-05       Impact factor: 4.129

10.  Risk Factors for Early and Late Complications after Laparoscopic Sleeve Gastrectomy in One-Year Observation.

Authors:  Paulina Głuszyńska; Inna Diemieszczyk; Łukasz Szczerbiński; Adam Krętowski; Piotr Major; Hady Razak Hady
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.